Esomeprazole immediate release tablets: Gastric mucosa ex vivo permeation, absorption and antisecretory activity in conscious rats-Reference-Cited by-同舟云学术

Esomeprazole immediate release tablets: Gastric mucosa ex vivo permeation, absorption and antisecretory activity in conscious rats

Published:2016-10 Issue: Volume:239 Page:203-210
ISSN:0168-3659
Container-title:Journal of Controlled Release
language:en
Short-container-title:Journal of Controlled Release

Author:

Benetti Camillo,Flammini Lisa,Vivo Valentina,Colombo Paolo,Colombo Gaia,Elviri Lisa,Scarpignato Carmelo,Buttini Francesca,Bettini Ruggero,Barocelli Elisabetta,Rossi Alessandra^ORCID

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference26 articles.

1. Clinical pharmacology and safety profile of esomeprazole, the first enantiomeracally pure proton pump inhibitor;Tonini;Dig. Liver Dis.,2001

2. Proton pump inhibitors: an update of their clinical use and pharmacokinetics;Shi;Eur. J. Clin. Pharmacol.,2008

3. A pharmacokinetic study comparing single and repeated oral doses of 20mg and 40mg omeprazole and its two optical isomers, S-omeprazole (esomeprazole) and R-omeprazole, in healthy subjects;Hassan-Ali;Eur. J. Clin. Pharmacol.,2005

4. Pharmacokinetic studies with esomeprazole, the (S)-isomer of omeprazole;Andersson;Clin. Pharmacokinet.,2001

5. Esomeprazole provides improved acid control vs. omeprazole in patients with symptoms of gastro-oesophageal reflux disease;Lind;Aliment. Pharmacol. Ther.,2000

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Investigation of a biopolymer-based pH-responsive and sustained release raft-gel-forming tablet of famotidine: In-vitro, ex-vivo, bioavailability and anti-ulcer evaluation in New Zealand albino rabbit;Journal of Drug Delivery Science and Technology;2023-09

2. Development of a Fast Onset Proton Pump Inhibitor: Comparison of Fixed-Dose Combination of Rabeprazole and Sodium Bicarbonate (YPI-011) to the Conventional Enteric-Coated Rabeprazole;Drug Design, Development and Therapy;2023-02

3. Formulation of Dosage Forms with Proton Pump Inhibitors: State of the Art, Challenges and Future Perspectives;Pharmaceutics;2022-09-25

4. Formulation development of loratadine immediate- release tablets using hot-melt extrusion and 3D printing technology;Journal of Drug Delivery Science and Technology;2022-08

5. Comparative Pharmacokinetics/Pharmacodynamics of Fixed-Dose Combination of Esomeprazole and Calcium Carbonate (AD-206) to the Conventional Esomeprazole;Drug Design, Development and Therapy;2021-12